不切除子宫的宫颈癌给药合剂化学免疫疗法:唤醒免疫细胞的免疫疗法

Baofa Yu, Feng Gao, Peng Jing, Guoqin Zheng, Yu Baofa
{"title":"不切除子宫的宫颈癌给药合剂化学免疫疗法:唤醒免疫细胞的免疫疗法","authors":"Baofa Yu, Feng Gao, Peng Jing, Guoqin Zheng, Yu Baofa","doi":"10.29011/2575-9760.11062","DOIUrl":null,"url":null,"abstract":"Background: Cervical cancer is one of the most common and deadly cancers in women, for whom with persistent infection of High-Risk Human Papillomavirus (HPV). Current treatment of cervical cancer involves radical hysterectomy, radiotherapy and chemotherapy or a combination. Objective: We to define if Hapten Enhanced Intratumoral Chemotherapy (HEIC) was effective in boosting immunity for effective treatment of cervical cancer lesions. Study Design: We used Single-Cell RNA Sequencing (scRNA-Seq) to obtain transcriptome profiles of 40239 cells from biopsies of cervical cancer lesions at the cervix directly from one patient before the start of HEIC and about 1 week after HEIC. The blood","PeriodicalId":515115,"journal":{"name":"Journal of Surgery","volume":"69 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hapten-Mediated Chemical Immune Therapy with Drug Administration into Cervical Cancer without Hysterectomy:Awakening Immune Cells for Immunotherapy\",\"authors\":\"Baofa Yu, Feng Gao, Peng Jing, Guoqin Zheng, Yu Baofa\",\"doi\":\"10.29011/2575-9760.11062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Cervical cancer is one of the most common and deadly cancers in women, for whom with persistent infection of High-Risk Human Papillomavirus (HPV). Current treatment of cervical cancer involves radical hysterectomy, radiotherapy and chemotherapy or a combination. Objective: We to define if Hapten Enhanced Intratumoral Chemotherapy (HEIC) was effective in boosting immunity for effective treatment of cervical cancer lesions. Study Design: We used Single-Cell RNA Sequencing (scRNA-Seq) to obtain transcriptome profiles of 40239 cells from biopsies of cervical cancer lesions at the cervix directly from one patient before the start of HEIC and about 1 week after HEIC. The blood\",\"PeriodicalId\":515115,\"journal\":{\"name\":\"Journal of Surgery\",\"volume\":\"69 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2575-9760.11062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2575-9760.11062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:宫颈癌是女性最常见也是最致命的癌症之一,高危人类乳头瘤病毒(HPV)会持续感染女性。目前治疗宫颈癌的方法包括根治性子宫切除术、放疗、化疗或综合疗法。我们的目标是确定合生元增强瘤内化疗(HEIC)是否能有效增强免疫力,从而有效治疗宫颈癌病变。研究设计:我们使用单细胞 RNA 测序(scRNA-Seq)技术获取了一名患者在 HEIC 开始前和 HEIC 结束后约 1 周宫颈癌病变活检组织中 40239 个细胞的转录组图谱。血液
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hapten-Mediated Chemical Immune Therapy with Drug Administration into Cervical Cancer without Hysterectomy:Awakening Immune Cells for Immunotherapy
Background: Cervical cancer is one of the most common and deadly cancers in women, for whom with persistent infection of High-Risk Human Papillomavirus (HPV). Current treatment of cervical cancer involves radical hysterectomy, radiotherapy and chemotherapy or a combination. Objective: We to define if Hapten Enhanced Intratumoral Chemotherapy (HEIC) was effective in boosting immunity for effective treatment of cervical cancer lesions. Study Design: We used Single-Cell RNA Sequencing (scRNA-Seq) to obtain transcriptome profiles of 40239 cells from biopsies of cervical cancer lesions at the cervix directly from one patient before the start of HEIC and about 1 week after HEIC. The blood
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信